Skip to main content
. 2016 Jun 7;9:21. doi: 10.1007/s12410-016-9383-z

Table 1.

T1 mapping measures available for assessment of myocardial fibrosis

Measure Unit Calculation Advantages Limitations
Native T1 ms T1 relaxation curve No gadolinium requirement (can use in severe renal failure) T1 signal represented a composite of myocardium and extracellular space
Post-contrast T1 ms T1 relaxation curve following gadolinium administration Improved sensitivity in identifying myocardial fibrosis Significant variability due to individual variation in gadolinium kinetics and time to imaging post-contrast injection
Partition coefficient (λ) Ratio Ratio of T1 signal change (pre- and post-contrast) in myocardium and blood pool Excellent scan-rescan reproducibility Does not account for plasma volume of distribution of gadolinium contrast
Extracellular volume fraction (ECV) % ECV = λ × (1—haematocrit) Excellent scan-rescan reproducibility. Conceptually attractive measure Gives a measure of relative fibrosis which may not best track changes in aortic stenosis
Fibrosis volume ml ECV × end-diastolic volume Quantitative measure of absolute fibrosis volume Limited evidence at current time
May require indexing to body size to enable comparison between individuals